en-us Reuters UK) - Britain's cost-effectiveness watchdog said it was minded not to recommend Roche's new arthritis drug RoActemra on the state health service, but could change its mind if the drugmaker handed over more data.The National Institute for Health and Clinical Excellence NICE said on Wednesday it wanted a...]]> Thu, 17 Dec 2009 03:58:21 -0800 Thu, 12 Nov 2009 07:06:24 -0800 Wed, 03 Dec 2008 07:23:31 -0800 CELG CELG Mon, 11 Aug 2008 22:09:20 -0700